Cytek Biosciences Inc (CTKB)
6.315
-0.08
(-1.17%)
USD |
NASDAQ |
May 08, 15:28
Cytek Biosciences Profit Margin (Quarterly): 9.45% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 9.45% |
September 30, 2023 | -13.45% |
June 30, 2023 | -8.83% |
March 31, 2023 | -18.35% |
December 31, 2022 | 7.30% |
September 30, 2022 | 4.12% |
June 30, 2022 | -1.49% |
March 31, 2022 | -5.76% |
Date | Value |
---|---|
December 31, 2021 | -3.06% |
September 30, 2021 | 4.13% |
June 30, 2021 | 8.78% |
March 31, 2021 | 0.42% |
December 31, 2020 | 18.29% |
September 30, 2020 | 26.06% |
June 30, 2020 | 42.39% |
March 31, 2020 | -4.66% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-18.35%
Minimum
Mar 2023
42.39%
Maximum
Jun 2020
4.08%
Average
2.27%
Median
Profit Margin (Quarterly) Benchmarks
Ainos Inc | -29.77K% |
OpGen Inc | -581.2% |
Zomedica Corp | -305.4% |
LENSAR Inc | -32.43% |
Eargo Inc (DELISTED) | -209.5% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -2.92% |
Return on Assets | -2.35% |
Return on Invested Capital | -2.90% |
Gross Profit Margin (Quarterly) | 56.75% |
Operating Margin (Quarterly) | -0.24% |
Return on Net Operating Assets | -4.73% |